Business Context and Reporting Period
Company: Safety Shot, Inc. (Note: Input metadata referenced "BONK, INC." but the filing text identifies the registrant as Safety Shot, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: May 29, 2025
Reporting Period: Event-based report regarding a material definitive agreement.
Business Context: The Company is an emerging growth company incorporated in Delaware, trading on the Nasdaq Capital Market under the symbol "SHOT". The filing details an amendment to a Liabilities Settlement Program with Silverback Capital Corporation (SCC) to resolve debts through the issuance of securities.
Key Financial Metrics
This filing is a Current Report (Form 8-K) and does not contain comprehensive financial statements (Revenue, Profit, Cash Flow, Margins, or Liquidity ratios). The text references a prior 10-Q for the quarter ended March 31, 2025, for detailed financial data, but does not reproduce those figures here.
- Debt Resolution Mechanism: The Company is paying down debts by issuing freely trading securities to SCC.
- Minimum Price Floor: Amended to $0.10 per share.
- Valuation Period: Amended to 20 days.
- Equity Issuance: The Company agreed to issue 1,000,000 shares of Common Stock to SCC as consideration for legal and transaction fees.
Material Changes Versus Prior Period
The filing reports specific amendments to the Settlement and Stipulation Agreement previously disclosed on May 27, 2025, and subject to court approval granted on May 20, 2025. Key changes include:
- Closing Price Definition: Redefined to mean the sale price of the last transaction of Common Stock completed during the trading session on the Amended Settlement Date.
- Valuation Period: Adjusted to a duration of twenty (20) days.
- Price Floor: The "Minimum Price Floor" was lowered/adjusted to $0.10.
- Fee Consideration: Addition of a new subsection requiring the issuance of 1,000,000 shares to SCC for legal and transaction fees.
- Debt Status: SCC has already paid certain claims and liabilities prior to this amendment; remaining obligations are detailed in attached Exhibit "C".
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the execution of the amendment to effectuate the debt settlement program. It references the "Management's Discussion and Analysis" in the May 14, 2025 10-Q for further details on subsequent liabilities.
Risks and Contingencies:
- Dilution Risk: The issuance of 1,000,000 shares for fees and the broader program of issuing securities for debt may result in shareholder dilution.
- Market Price Sensitivity: The settlement terms rely on the "Closing Price" and a "Minimum Price Floor" of $0.10, making the final debt resolution value sensitive to stock price volatility.
- Legal Contingency: The program was subject to court approval, which was granted on May 20, 2025. Future obligations depend on the terms of the attached Claim Purchase Agreements.
Investor Verification Checklist
- Verify the total number of shares to be issued under the full Liabilities Settlement Program (beyond the 1,000,000 shares for fees) by reviewing the referenced 10-Q and Exhibit "C".
- Confirm the current market price of "SHOT" relative to the $0.10 minimum price floor to assess the potential valuation of the debt settlement.
- Review the attached Exhibit 10.1 (Amendment) and Exhibit 10.2 (Settlement Agreement) for specific terms regarding the "Valuation Period" and "Closing Price" calculations.
- Check the May 14, 2025 10-Q filing for the Company's total outstanding debt and liquidity position prior to this settlement.
- Monitor for any subsequent filings regarding the actual issuance of shares or further amendments to the settlement terms.